Home > News > UML nanotech research spawns new biopharm company
July 12th, 2006
UML nanotech research spawns new biopharm company
Abstract:
UMass Lowell's Louis Petrovic describes the current nanotechnology boom in three words: "Small is good." But the university is hoping that Encapsion, a new biopharmaceutical company spawned by research at UMass Lowell, will be big -- very big.
Source:
lowellsun.com
Bookmark:
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013